News
Discover Marchex's Q2 2025 results: revenue growth, AI-driven innovations, and new partnerships. Learn about the Engage platform & future plans.
Q2 2025 Management View Claude Maraoui, CEO, highlighted the first full quarter of EMROSI's market launch, reporting "second ...
Theravance Biopharma, Inc. ( NASDAQ: TBPH) Q2 2025 Earnings Conference Call August 12, 2025 5:00 PM ET Aine Miller - Senior VP of Development & Head of Ireland Office Aziz Sawaf - Senior VP & CFO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback